CI vs GILD · P/E 2.4, rev $274.90B vs P/E 18, rev $29.44B
Cigna Corp (CI) versus Gilead Sciences Inc (GILD) — a side-by-side from cached financials, not a winner call.
Cigna Corp (CI) is a healthcare plans company listed on US.
Gilead Sciences Inc (GILD) is a drug manufacturers - general company listed on US.
Latest reported CI revenue for 2025-12-31 was $274.90B. Net income was $5.96B. Revenue was up 11.2% from 2024-12-31 to 2025-12-31. CI currently screens at market cap $71.62B and trailing P/E 2.4.
Latest reported GILD revenue for 2025-12-31 was $29.44B. Net income was $8.51B. Revenue was up 2.4% from 2024-12-31 to 2025-12-31. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
CI currently screens at market cap $71.62B and trailing P/E 2.4. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
Not investment advice. Open the CI and GILD stock pages for the full models.
Not investment advice.